MOA animation for an investor deck: what a Series A audience needs to see

A fundraising MOA animation exists to make a mechanism evaluable in under ninety seconds, by an audience without the background to reconstruct the science from a slide. Investors do not read an unexplained mechanism as a broken one. Investors read an unexplained mechanism as an unpriceable one — and unpriceable assets get discounted. Series A and Series B raises are where mechanism of action animation earns its cost, on terms quite different from a congress version.

The audience is not your scientific audience

This is where most fundraising MOA animations go wrong. They are built by people who understand the science deeply, reviewed by other people who understand it deeply, and shown to a room where perhaps one person has a relevant background.

A Series A audience is typically some mix of generalist partners, an associate who did the diligence, and possibly one scientific advisor. The animation has to work for the generalist without insulting the advisor. In practice that means:

• One mechanism, not the whole platform. The temptation is to show everything the technology can do. The effect is that nothing lands. Pick the single mechanism that carries the investment case.
• The “so what” has to be visible. Showing a molecule binding a receptor is not the point. Showing what stops happening as a result is.
• Scale transitions need to be explicit. Non-specialists lose orientation the moment the camera moves from tissue to cell to molecule without signposting. Specialists do this translation automatically and forget that others do not.

What it should not do

It should not carry the claims. An animation is a comprehension tool, not evidence. The data slides make the claims; the animation makes the mechanism understandable enough that the data slides mean something. Animations that drift into implying efficacy create problems later, particularly if the same asset gets reused in a regulated context.

It should not have a voiceover if you are presenting live. You are the voiceover. A narrated animation and a live presenter compete with each other, and the presenter loses. Build the silent cut for the room and add narration only for the version that gets emailed around afterwards — which is a different edit, and worth planning for at storyboard stage rather than retrofitting.

It should not be three minutes long. In a pitch you have the room’s attention for a genuinely short window before they return to the deck. Sixty to ninety seconds is the format for a reason.

How the fundraising cut differs from the congress cut

Teams often assume one animation serves both. It can — but only if that is decided at the start.

	Investor version	Congress version
Audience	Mostly generalist	Specialist
Detail	The mechanism that carries the case	Full pathway, including nuance
Length	60–90 seconds	Often longer
Narration	Usually none — you present	Often narrated or captioned
Emphasis	Consequence and differentiation	Mechanistic completeness

The renders can be shared. The edit, the pacing and often the level of on-screen labelling cannot. Building the longer specialist version first and cutting down is usually cheaper than the reverse, but it only works if the framing accounts for both from the storyboard onward.

The practical sequence

If you are raising in the next few months and want an animation in the deck, work backwards from the first meeting rather than the close. The animation needs to exist before the conversations start, not before the term sheet — and a 60–90 second piece typically takes four to six weeks from script to final, with the science agreed in writing before anything is animated.

That last part matters more than the schedule. The most expensive thing that can happen to a fundraising animation is discovering at the render stage that the mechanism was mischaracterised — because by then you are paying for it twice, and the meeting is next week.

If you want to see how that process is structured, it is written out here, and what it costs is published rather than quoted on request. If you are pre-revenue and the science is the pitch, what that changes about the brief is set out separately.